Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups
One of the world’s leading Covid-19 experimental vaccines produces an immune response in both older and young adults, raising hopes of a path out of the gloom and economic destruction wrought by the novel coronavirus.
The vaccine, developed by the University of Oxford, also triggers lower adverse responses among elderly people, said the British drug maker AstraZeneca, which is helping to manufacture the vaccine, on Monday.
Related: Covid vaccine tracker: when will a coronavirus vaccine be ready?
Related: At 75, I’ve volunteered for a Covid vaccine trial. It could set people free
